Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic Keratitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating outcomes of cyclosporine eye drops for managing herpetic keratitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporine Eye Drops (cyclosporine)

Snippet

Sponsor: Farwaniya Hospital | Conditions: Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis | Phase 4 | Status: COMPLETED